The Clinical Development and Medical Affairs team at PMV Pharmaceuticals leads the design, execution, and analysis of clinical trials to evaluate the efficacy and safety of first-in-class p53 regulators. They also oversee drug safety, pharmacovigilance, and engage with regulatory authorities to ensure compliance and facilitate the advancement of cancer treatments.
View all